Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Depreciation & Amortization (CF) (2021 - 2026)

MoonLake Immunotherapeutics' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $800000.0 for Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 100.0% to $800000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Mar 2026, up 107.0% year-over-year, with the annual reading at $2.6 million for FY2025, 88.88% up from the prior year.
  • Depreciation & Amortization (CF) came in at $800000.0 for Q1 2026, up from $751000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $800000.0 in Q1 2026 to a low of $2488.0 in Q1 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $328000.0 (2024), against an average of $283912.7.
  • Year-over-year, Depreciation & Amortization (CF) crashed 33.84% in 2022 and then skyrocketed 11605.69% in 2024.
  • MoonLake Immunotherapeutics' Depreciation & Amortization (CF) stood at $3289.0 in 2022, then changed by 0.0% to $3289.0 in 2023, then surged by 11605.69% to $385000.0 in 2024, then surged by 95.06% to $751000.0 in 2025, then grew by 6.52% to $800000.0 in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Depreciation & Amortization (CF) are $800000.0 (Q1 2026), $751000.0 (Q4 2025), and $745000.0 (Q3 2025).